Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (2.74%)
Market Cap: £3.24m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Statement re Possible Offer

17 Oct 2007 13:39

Feedback PLC17 October 2007 17 October 2007 Feedback Plc (the "Company") Statement in respect of a possible offer Following the rise in the Company's share price today, the Board confirms thatit is in very preliminary discussions that may or may not lead to an offer forthe entire issued share capital of the Company. The Board emphasises that thesediscussions are at a very early stage and there can be no certainty that anoffer will be made. A further announcement will be made in due course. In accordance with Rule 2.10 of the City Code, as at the close of business on 16October 2007, the Company had 82,480,060 ordinary shares of 0.25 pence each inissue. The International Securities Identification Number (ISIN) for theseshares is GB0003340550. Enquiries: Feedback plc 01892 653 322David Sawyer, Chief Executive Charles Stanley SecuritiesNominated Adviser 020 7149 6457Philip Davies DEALING DISCLOSURE REQUIREMENTS Under the provisions of Rule 8.3 of the City Code, if any person is, or becomes,"interested" (directly or indirectly) in one per cent. or more of any class of"relevant securities" of the Company, all "dealings" in any "relevantsecurities" of the Company (including by means of an option in respect of, or aderivative referenced to, any such "relevant securities") must be publiclydisclosed by no later than 3.30 p.m. (London time) on the London business dayfollowing the date of the relevant transaction. This requirement will continueuntil the date on which any offer (if made) becomes, or is declared,unconditional as to acceptances, lapses or is otherwise withdrawn or the date onwhich the "offer period" otherwise ends. If two or more persons act togetherpursuant to an agreement or understanding, whether formal or informal, toacquire an "interest" in "relevant securities" of the Company, they will bedeemed to be a single person for the purpose of Rule 8.3. Under the provisions of Rule 8.1 of the City Code, all "dealings" in "relevantsecurities" of the Company by an offeror or the Company, or any of theirrespective "associates", must be disclosed by no later than 12.00 noon (Londontime) on the London business day following the date of the relevant transaction. A disclosure table, giving details of the companies whose "relevant securities"and "dealings" should be disclosed, and the number of securities in issue, canbe found on the Panel's website at www.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary, when a person has long economicexposure, whether conditional or absolute, to changes in the price ofsecurities. In particular, a person will be treated as having an "interest" byvirtue of the ownership or control of securities, or by virtue of any option inrespect of, or derivative referenced to, securities. Terms in quotation marks are defined in the City Code, which can also be foundon the Panel's website at www.thetakeoverpanel.org.uk. If you are in any doubtas to whether or not you are required to disclose a dealing under Rule 8, youshould consult the Panel. If you are in any doubt as to the application of Rule 8 to you, please contactan independent financial adviser authorised under the Financial Services andMarkets Act 2000, consult the Panel's website at www.thetakeoverpanel.org.uk orcontact the Panel on telephone number +44 (0) 20 7638 0129; fax number +44 (0)20 7236 7013. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Sep 20187:00 amRNSTexRAD® ordered by Samsung Medical Centre in Seoul
17th Aug 20182:02 pmRNSDirector/PDMR Shareholding
15th Aug 20187:00 amRNSFirst GE Healthcare order for TexRAD®
1st Aug 20181:19 pmRNSDirector/PDMR Shareholding
20th Jul 20187:00 amRNSDirectorate Change
6th Jul 20187:00 amRNSJoint broker update
29th Jun 20183:20 pmRNSDirector/PDMR Shareholding
27th Jun 20187:00 amRNSGrant of Options and Director/PDMR Dealing
22nd Jun 20182:10 pmRNSResult of General Meeting
8th Jun 201810:36 amRNSHolding(s) in Company
7th Jun 20187:05 amRNSNotice of General Meeting
7th Jun 20187:00 amRNSRevised strategy to build a global company
1st Jun 20187:00 amRNSAppointment of new Medical Director
10th May 20189:27 amRNSHolding(s) in Company
4th May 20186:09 pmRNSHolding(s) in Company
1st May 20187:00 amRNSDirector/PDMR Shareholding
30th Apr 20185:00 pmRNSTotal Voting Rights
27th Apr 20187:00 amRNSTwo-year contract with Royal Papworth Hospital
25th Apr 20182:05 pmRNSSecond Price Monitoring Extn
25th Apr 20182:00 pmRNSPrice Monitoring Extension
25th Apr 20187:00 amRNSDistribution agreement with GE Healthcare
17th Apr 20187:00 amRNSHolding(s) in Company
16th Apr 20187:30 amRNSNew Company Structure and Directorate Change
16th Apr 20187:25 amRNSAppointment of non-executive director
9th Apr 20182:39 pmRNSHolding(s) in Company
29th Mar 20187:00 amRNSEquity Fundraising to raise £440,000
21st Mar 20189:01 amRNSHolding(s) in Company
16th Mar 20185:11 pmRNSHolding(s) in Company
16th Mar 20187:00 amRNSDirectorate Change
8th Mar 20188:48 amRNSHolding(s) in Company
7th Mar 20182:39 pmRNSHolding(s) in Company
1st Mar 20181:03 pmRNSHolding(s) in Company
26th Feb 20187:00 amRNSHalf-year Report
14th Feb 20187:00 amRNSDirectorate Change
9th Feb 201812:04 pmRNSHolding(s) in Company
5th Feb 20181:56 pmRNSHolding(s) in Company
28th Dec 20175:42 pmRNSHolding(s) in Company
28th Dec 20175:19 pmRNSTotal Voting Rights
20th Dec 20179:33 amRNSHolding(s) in Company
30th Nov 20174:38 pmRNSResult of AGM
22nd Nov 20179:37 amRNSHolding(s) in Company
22nd Nov 20177:00 amRNSPresentation at RSNA 2017
20th Nov 201712:40 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFirst CE marked release of TexRAD® technology
7th Nov 20177:00 amRNSFinal Results
14th Sep 20177:00 amRNSHolding(s) in Company
31st Jul 20175:00 pmRNSTotal Voting Rights
28th Jul 201710:53 amRNSCCI Exclusive Distributor agreement with Boya
30th Jun 20172:21 pmRNSHolding(s) in Company
30th Jun 201712:41 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.